XML 44 R33.htm IDEA: XBRL DOCUMENT
v3.24.1.u1

Stockholders' Equity (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2024
Stockholders' Equity Note [Abstract] |
Schedule of Preferred Stock Dividend Declaration and Payment | The following table presents cash dividends declared by the Company on its Series B Preferred Stock from January 1, 2023 through March 31, 2024:
Declaration Date |  | Record Date |  | Payment Date |  | Dividend Per Share
February 20, 2024 |  | March 5, 2024 |  | March 28, 2024 |  | $0.46875
November 21, 2023 |  | December 4, 2023 |  | December 29, 2023 |  | 0.46875
August 17, 2023 |  | September 5, 2023 |  | September 29, 2023 |  | 0.46875
May 22, 2023 |  | June 5, 2023 |  | June 30, 2023 |  | 0.46875
February 21, 2023 |  | March 6, 2023 |  | March 31, 2023 |  | 0.46875
Schedule of Cash Dividends on its Preferred Stock and Common Stock | The following table presents cash dividends declared by the Company on its Series C Preferred Stock from January 1, 2023 through March 31, 2024:
Declaration Date |  | Record Date |  | Payment Date |  | Dividend Per Share
February 20, 2024 |  | March 5, 2024 |  | March 28, 2024 |  | $0.40625
November 21, 2023 |  | December 4, 2023 |  | December 29, 2023 |  | 0.40625
August 17, 2023 |  | September 5, 2023 |  | September 29, 2023 |  | 0.40625
May 22, 2023 |  | June 5, 2023 |  | June 30, 2023 |  | 0.40625
February 21, 2023 |  | March 6, 2023 |  | March 31, 2023 |  | 0.40625
The following table presents cash dividends declared by the Company on its common stock from January 1, 2023 through March 31, 2024:
Declaration Date |  | Record Date |  | Payment Date |  | Dividend Per Share |
March 7, 2024 |  | March 28, 2024 |  | April 30, 2024 |  | $0.35 | (1)
December 13, 2023 |  | December 29, 2023 |  | January 31, 2024 |  | 0.35 |
September 20, 2023 |  | October 2, 2023 |  | October 31, 2023 |  | 0.35 |
June 15, 2023 |  | June 30, 2023 |  | July 31, 2023 |  | 0.35 |
March 10, 2023 |  | March 31, 2023 |  | April 28, 2023 |  | 0.35 |
(1) At March 31, 2024, the Company had accrued dividends and dividend equivalents payable of $36.0 million related to the common stock dividend declared on March 7, 2024.
Schedule of Changes in Balances of each Component of the Entity's AOCI | The following table presents changes in the balances of each component of the Company’s AOCI for the three months ended March 31, 2024:
|  | Three Months Ended March 31, 2024 |  |
(In Thousands) |  | Net Unrealized Gain/(Loss) on AFS Securities |  | Net Unrealized Gain/(Loss) on Financing Agreements (1) |  | Total AOCI |  |  |  |  |  |
Balance at beginning of period |  | $ | 17,698 |  |  | $ | — |  |  | $ | 17,698 |  |  |  |  |  |  |
OCI before reclassifications |  | 1,828 |  |  | — |  |  | 1,828 |  |  |  |  |  |  |
Amounts reclassified from AOCI |  | — |  |  | — |  |  | — |  |  |  |  |  |  |
Net OCI during the period (2) |  | 1,828 |  |  | — |  |  | 1,828 |  |  |  |  |  |  |
Balance at end of period |  | $ | 19,526 |  |  | $ | — |  |  | $ | 19,526 |  |  |  |  |  |  |
(1)Net Unrealized Gain/(Loss) on Financing Agreements at Fair Value due to changes in instrument-specific credit risk. (2) For further information regarding changes in OCI, see the Company’s consolidated statements of comprehensive income/(loss). The following table presents changes in the balances of each component of the Company’s AOCI for the three months ended March 31, 2023:
|  | Three Months Ended March 31, 2023 |  |
(In Thousands) |  | Net Unrealized Gain/(Loss) on AFS Securities |  | Net Unrealized Gain/(Loss) on Financing Agreements (1) |  | Total AOCI |  |  |  |  |  |
Balance at beginning of period |  | $ | 21,341 |  |  | $ | — |  |  | $ | 21,341 |  |  |  |  |  |  |
OCI before reclassifications |  | (1,116) |  |  | — |  |  | (1,116) |  |  |  |  |  |  |
Amounts reclassified from AOCI |  | — |  |  | — |  |  | — |  |  |  |  |  |  |
Net OCI during the period (2) |  | (1,116) |  |  | — |  |  | (1,116) |  |  |  |  |  |  |
Balance at end of period |  | $ | 20,225 |  |  | $ | — |  |  | $ | 20,225 |  |  |  |  |  |  |
(1) Net Unrealized Gain/(Loss) on Financing Agreements at Fair Value due to changes in instrument-specific credit risk. (2) For further information regarding changes in OCI, see the Company’s consolidated statements of comprehensive income/(loss).

X
- Definition Tabular disclosure of information pertaining to declaration and payment of dividends on preferred stock. This item may also include dates pertaining to declaration, recording and payment of dividends on preferred stock, the amount of dividends declared or paid in aggregate as well as for each share. + References No definition available. + Details
Name: | mfa_ScheduleOfPreferredStockDividendDeclarationAndPaymentTableTextBlock
Namespace Prefix: | mfa_
Data Type: | dtr-types1:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of information related to dividends declared, including paid and unpaid dividends. + References No definition available. + Details
Name: | us-gaap_DividendsDeclaredTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the components of accumulated other comprehensive income (loss). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 14A -Publisher FASB -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 45 -Paragraph 20 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20 + Details
Name: | us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration